-
Zaiding Pharmaceutical: Ruiputinib has been approved by the state for the treatment of ROS1 positive non-small cell lung cancer patients
Southern Finance and Economics, May 13 (Xinhua) - Zaiding Pharmaceutical Hong Kong Stock Exchange announced that the National Medical Products Administration of China has approved the use of reprotin ... -
AstraZeneca lung cancer targeted drug Teresa has been approved for new indications in China
AstraZeneca announced on June 26 that the National Medical Products Administration of China officially approved Teresa& on June 18, 2024; reg; The combination of pemetrexed and platinum based chemoth ... -
Incidence rate of lung cancer death in women is higher than that in men
Susan Wojcicki, former CEO of YouTube and senior executive of Google, passed away on August 10th local time due to lung cancer at the age of 56. Wojcicki's husband announced the news of his wife's de ... -
Merck PD-1 inhibitor pembrolizumab's fourth lung cancer indication approved in China
On December 3rd, Merck announced that its PD-1 inhibitor pembrolizumab (trade name: CRDA®) We have obtained approval from the National Medical Products Administration (NMPA) of China to combine p ...